B lymphocyte alterations accompany abatacept resistance in new-onset type 1 diabetes
Ontology highlight
ABSTRACT: Peripheral blood samples were collected from subjects enrolled in the TrialNet study TN-09. This was a phase II study of the effects of the T cell costimulation inhibitor CTLA4-Ig (abatacept) in new-onset T1D. Total RNA was isolated from whole blood samples and then globin-reduced. RNAseq libraries were prepared from the globin-reduced RNA.
ORGANISM(S): Homo sapiens
PROVIDER: GSE124284 | GEO | 2019/02/28
REPOSITORIES: GEO
ACCESS DATA